Astrazeneca plc ADR (NASDAQ: AZN) Stock’s Performance and Current Analyst Sentiments

In the last trading session, 4.84 million Astrazeneca plc ADR (NASDAQ:AZN) shares changed hands as the company’s beta touched 0.52. With the company’s per share price at $68.26 changed hands at -$0.47 or -0.68% during last session, the market valuation stood at $211.65B. AZN’s last price was a discount, traded about -12.16% off its 52-week high of $76.56. The share price had its 52-week low at $60.47, which suggests the last value was 11.41% up since then. When we look at Astrazeneca plc ADR’s average trading volume, we note the 3-month average coming to 6.41 million.

Astrazeneca plc ADR (NASDAQ:AZN) trade information

Instantly AZN was in red as seen at the end of in last trading. With action -0.21%, the performance over the past five days has been red. The drop to weekly highs of 70.07 subtracted -0.68% to the stock’s daily price. The company’s shares are showing year-to-date upside of 1.36%, with the 5-day performance at -0.21% in the red. However, in the 30-day time frame, Astrazeneca plc ADR (NASDAQ:AZN) is 2.95% up.

Astrazeneca plc ADR (AZN) estimates and forecasts

Data shows that the Astrazeneca plc ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 1.39% over the past 6 months, a 10.74% in annual growth rate that is considerably higher than the industry average of 3.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.72%. The 2024 estimates are for Astrazeneca plc ADR earnings to increase by 11.79%, but the outlook for the next 5-year period is at 13.20% per year.

AZN Dividends

Astrazeneca plc ADR is expected to release its next quarterly earnings report in May. The 2.12% annual yield figure for the share gives it an annual dividend of 1.45. It is important to note, however, that the 2.12% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.